India's leading generic maker Cipla Ltd has posted 39.3 per cent jump in net profit and touched to Rs 1,082 crore during the financial year ending March 31 2010 from Rs 777 crore in the previous year.
Cadence Pharmaceuticals is seeking US FDA approval for intravenous acetaminophen injection (Ofirmev).
A drug-less device to relieve chronic pain RestoreSensor neurostimulator by Medtronic Inc, is currently in clinical trials.
Estrogen-progesterol combination contarcepitive pill Natazia (estradiol valerate and estradiol valerate/dienogest) by Bayer Healthcare will soon be launched in US.
Merck's cervical cancer vaccine Gardasil will be offered to girls and young women between the ages of 12 and 18 in Bhutan.